Discovery of TAK-659 an orally available investigational inhibitor of Spleen Tyrosine Kinase (SYK)

201660 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Bioorganic & Medicinal Chemistry Letters

Volume 26, Issue 24, pp. 5947-5950

Field-Weighted Citation Impact: 1.71